Producción científica por año
Producción científica por año
Huella digital
Profundizar en los temas de investigación en los que Yaxia Yuan está activo. Estas etiquetas de temas provienen de las obras de esta persona. Juntos, forma una huella digital única.
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
Colaboración externa reciente a nivel de país/territorio. Para consultar los detalles, haga clic en los puntos o
-
Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
Nayak, D., Lv, D., Yuan, Y., Zhang, P., Hu, W., Nayak, A., Ruben, E. A., Lv, Z., Sung, P., Hromas, R., Zheng, G., Zhou, D. & Olsen, S. K., dic 2024, En: Nature communications. 15, 1, 2743.Producción científica: Article › revisión exhaustiva
Acceso abierto4 Citas (Scopus) -
PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis
Yang, X., Liu, Z., Tang, W., Pratap, U. P., Collier, A. B., Altwegg, K. A., Gopalam, R., Li, X., Yuan, Y., Zhou, D., Lai, Z., Chen, Y., Sareddy, G. R., Valente, P. T., Kost, E. R., Viswanadhapalli, S. & Vadlamudi, R. K., sept 2024, En: Molecular oncology. 18, 9, p. 2136-2156 21 p.Producción científica: Article › revisión exhaustiva
Acceso abierto3 Citas (Scopus) -
Total synthesis/semi-synthesis of natural isopentenyl flavonoids with inhibitory activity on NLRP3 inflammasome
Hu, Y., Su, M., Kong, Y., Jiang, C., Yuan, Y., Chen, X. & Ma, L., jul 15 2024, En: Bioorganic and Medicinal Chemistry Letters. 107, 129777.Producción científica: Article › revisión exhaustiva
1 Cita (Scopus) -
Design and synthesis of indol-2-one derivatives as potential RET inhibitors
Li, Z., Sun, K., Xu, Y., Zhu, F., Mao, Z., Wang, Y., Yuan, Y., Qiu, T., Chen, X. & Ma, L., dic 15 2023, En: Bioorganic and Medicinal Chemistry Letters. 97, 129538.Producción científica: Article › revisión exhaustiva
-
Elemene sensitizes pancreatic cancer cells to bortezomib by enhancing proteasome inhibition via molecular patch mechanism
Hou, S., Li, Z., Chen, X., Wang, W., Duan, T., Scampavia, L., Yuan, Y., Spicer, T. P., Chen, X. & Xie, T., dic 2023, En: Signal Transduction and Targeted Therapy. 8, 1, 87.Producción científica: Letter › revisión exhaustiva
Acceso abierto10 Citas (Scopus)
Conjuntos de datos
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029.v1, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029/1
Dataset
-
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5075029, https://springernature.figshare.com/collections/Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/5075029
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550
Dataset
-
Additional file 3 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726550.v1, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726550/1
Dataset
-
Additional file 2 of Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y. (Creator), Khan, S. (Creator), Huo, Z. (Creator), Lv, D. (Creator), Zhang, X. (Creator), Liu, X. (Creator), Yuan, Y. (Creator), Hromas, R. (Creator), Xu, M. (Creator), Zheng, G. (Creator) & Zhou, D. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12726547.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_Proteolysis_targeting_chimeras_PROTACs_are_emerging_therapeutics_for_hematologic_malignancies/12726547/1
Dataset